Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Price:
1 615
IDR
-0.31%
Market Cap:
1.8T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DVLA Alert
Darya-Varia Laboratoria Tbk PT
1615
-5 (-0.31%)
| 52 Week Range |
1 390
1 810
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Darya-Varia Laboratoria Tbk PT
Balance Sheet
Balance Sheet Decomposition
Darya-Varia Laboratoria Tbk PT
Darya-Varia Laboratoria Tbk PT
| Current Assets | 1.6T |
| Cash & Short-Term Investments | 437.9B |
| Receivables | 724B |
| Other Current Assets | 455.9B |
| Non-Current Assets | 633.3B |
| Long-Term Investments | 37.9B |
| PP&E | 459.9B |
| Intangibles | 50.2B |
| Other Non-Current Assets | 85.4B |
| Current Liabilities | 610.4B |
| Accounts Payable | 154.1B |
| Accrued Liabilities | 372.3B |
| Other Current Liabilities | 84B |
| Non-Current Liabilities | 163.7B |
| Long-Term Debt | 709.4m |
| Other Non-Current Liabilities | 163B |
Balance Sheet
Darya-Varia Laboratoria Tbk PT
Darya-Varia Laboratoria Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
47 468
|
55 259
|
98 379
|
142 882
|
227 117
|
83 047
|
242 312
|
378 296
|
334 021
|
227 043
|
|
| Cash |
47 468
|
55 259
|
98 379
|
142 882
|
227 117
|
83 047
|
242 312
|
378 296
|
334 021
|
227 043
|
|
| Short-Term Investments |
274 389
|
367 000
|
274 000
|
308 000
|
79 000
|
256 000
|
23 000
|
205 000
|
23 000
|
13 000
|
|
| Total Receivables |
356 357
|
404 937
|
469 495
|
491 776
|
577 403
|
565 430
|
721 573
|
475 012
|
568 209
|
733 372
|
|
| Accounts Receivables |
351 273
|
398 511
|
461 789
|
478 940
|
566 810
|
550 559
|
708 985
|
468 413
|
556 434
|
699 708
|
|
| Other Receivables |
5 084
|
6 427
|
7 706
|
12 837
|
10 593
|
14 871
|
12 588
|
6 600
|
11 775
|
33 664
|
|
| Inventory |
227 050
|
198 658
|
209 778
|
203 862
|
280 691
|
333 781
|
374 428
|
429 976
|
508 000
|
452 646
|
|
| Other Current Assets |
20 030
|
17 976
|
17 316
|
29 136
|
39 162
|
41 953
|
38 928
|
38 378
|
14 745
|
14 921
|
|
| Total Current Assets |
925 294
|
1 043 830
|
1 068 967
|
1 175 656
|
1 203 372
|
1 280 212
|
1 400 242
|
1 526 662
|
1 447 974
|
1 440 981
|
|
| PP&E Net |
267 040
|
258 265
|
404 599
|
395 989
|
394 752
|
392 924
|
436 706
|
401 254
|
400 439
|
436 136
|
|
| PP&E Gross |
267 040
|
258 265
|
404 599
|
395 989
|
394 752
|
392 924
|
436 706
|
401 254
|
400 439
|
436 136
|
|
| Accumulated Depreciation |
206 637
|
234 056
|
253 802
|
274 211
|
299 245
|
331 356
|
372 705
|
418 514
|
451 491
|
498 585
|
|
| Intangible Assets |
10 279
|
15 031
|
15 031
|
4 752
|
4 752
|
4 752
|
4 752
|
47 208
|
48 479
|
44 969
|
|
| Goodwill |
0
|
0
|
0
|
10 279
|
10 279
|
10 279
|
10 279
|
10 279
|
10 279
|
8 891
|
|
| Note Receivable |
0
|
0
|
0
|
10 832
|
9 529
|
9 278
|
6 285
|
5 923
|
7 789
|
8 755
|
|
| Long-Term Investments |
4 675
|
8 850
|
16 311
|
15 427
|
33 415
|
100 743
|
82 277
|
45 041
|
42 430
|
39 818
|
|
| Other Long-Term Assets |
33 952
|
50 302
|
26 457
|
27 951
|
26 723
|
31 772
|
46 170
|
46 545
|
51 751
|
62 620
|
|
| Other Assets |
0
|
0
|
0
|
10 279
|
10 279
|
10 279
|
10 279
|
10 279
|
10 279
|
8 891
|
|
| Total Assets |
1 241 240
N/A
|
1 376 278
+11%
|
1 531 366
+11%
|
1 640 886
+7%
|
1 682 822
+3%
|
1 829 961
+9%
|
1 986 712
+9%
|
2 082 911
+5%
|
2 009 139
-4%
|
2 042 172
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
37 155
|
52 659
|
51 570
|
68 140
|
102 276
|
142 498
|
130 439
|
151 155
|
107 613
|
93 413
|
|
| Accrued Liabilities |
107 597
|
199 676
|
241 507
|
277 326
|
248 858
|
206 479
|
324 563
|
332 660
|
313 695
|
308 744
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22 981
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
38 671
|
31 928
|
61 869
|
71 043
|
40 352
|
64 241
|
989
|
0
|
414
|
430
|
|
| Other Current Liabilities |
4 875
|
12 036
|
19 482
|
25 115
|
25 051
|
26 226
|
99 852
|
88 305
|
60 621
|
101 742
|
|
| Total Current Liabilities |
188 297
|
296 298
|
374 428
|
441 623
|
416 537
|
439 444
|
555 844
|
595 102
|
482 344
|
504 329
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 474
|
1 044
|
|
| Other Liabilities |
105 488
|
106 463
|
77 358
|
82 963
|
66 023
|
84 438
|
104 581
|
96 397
|
121 701
|
132 367
|
|
| Total Liabilities |
293 785
N/A
|
402 761
+37%
|
451 786
+12%
|
524 586
+16%
|
482 560
-8%
|
523 882
+9%
|
660 425
+26%
|
691 499
+5%
|
605 519
-12%
|
637 740
+5%
|
|
| Equity | |||||||||||
| Common Stock |
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
280 000
|
|
| Retained Earnings |
613 050
|
642 829
|
755 855
|
806 512
|
887 758
|
989 923
|
1 030 755
|
1 099 817
|
1 119 272
|
1 130 089
|
|
| Additional Paid In Capital |
77 828
|
77 828
|
77 828
|
77 828
|
77 829
|
78 162
|
78 274
|
78 274
|
78 274
|
78 274
|
|
| Treasury Stock |
8 561
|
8 561
|
8 561
|
8 561
|
8 517
|
2 615
|
0
|
0
|
0
|
0
|
|
| Other Equity |
14 863
|
18 580
|
25 543
|
39 480
|
36 807
|
39 391
|
62 742
|
66 679
|
73 925
|
83 930
|
|
| Total Equity |
947 455
N/A
|
973 517
+3%
|
1 079 580
+11%
|
1 116 300
+3%
|
1 200 262
+8%
|
1 306 079
+9%
|
1 326 287
+2%
|
1 391 412
+5%
|
1 403 621
+1%
|
1 404 432
+0%
|
|
| Total Liabilities & Equity |
1 241 240
N/A
|
1 376 278
+11%
|
1 531 366
+11%
|
1 640 886
+7%
|
1 682 822
+3%
|
1 829 961
+9%
|
1 986 712
+9%
|
2 082 911
+5%
|
2 009 139
-4%
|
2 042 172
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1 116
|
1 116
|
1 116
|
1 116
|
1 116
|
1 119
|
1 120
|
1 120
|
1 120
|
1 120
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
